Correlation Between Cns Pharmaceuticals and Absci Corp
Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Absci Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Absci Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cns Pharmaceuticals and Absci Corp, you can compare the effects of market volatilities on Cns Pharmaceuticals and Absci Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Absci Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Absci Corp.
Diversification Opportunities for Cns Pharmaceuticals and Absci Corp
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cns and Absci is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Absci Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Absci Corp and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Absci Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Absci Corp has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Absci Corp go up and down completely randomly.
Pair Corralation between Cns Pharmaceuticals and Absci Corp
Given the investment horizon of 90 days Cns Pharmaceuticals is expected to generate 1.42 times more return on investment than Absci Corp. However, Cns Pharmaceuticals is 1.42 times more volatile than Absci Corp. It trades about -0.1 of its potential returns per unit of risk. Absci Corp is currently generating about -0.38 per unit of risk. If you would invest 15.00 in Cns Pharmaceuticals on August 25, 2024 and sell it today you would lose (3.00) from holding Cns Pharmaceuticals or give up 20.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cns Pharmaceuticals vs. Absci Corp
Performance |
| Timeline |
| Cns Pharmaceuticals |
| Absci Corp |
Cns Pharmaceuticals and Absci Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cns Pharmaceuticals and Absci Corp
The main advantage of trading using opposite Cns Pharmaceuticals and Absci Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Absci Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Absci Corp will offset losses from the drop in Absci Corp's long position.| Cns Pharmaceuticals vs. ZyVersa Therapeutics | Cns Pharmaceuticals vs. Immix Biopharma | Cns Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Cns Pharmaceuticals vs. Ocean Biomedical |
| Absci Corp vs. Eliem Therapeutics | Absci Corp vs. HCW Biologics | Absci Corp vs. Scpharmaceuticals | Absci Corp vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Correlations Find global opportunities by holding instruments from different markets |